Ryan Walker
About Ryan Walker
Ryan Walker is the Vice President and Associate General Counsel at Jefferies, with a background in capital markets law and experience at Cooley LLP, Weil, Gotshal & Manges LLP, and the U.S. Securities and Exchange Commission.
Current Position at Jefferies
Ryan Walker is currently the Vice President and Associate General Counsel at Jefferies. He began this role in 2023 and operates out of New York, New York. His responsibilities likely involve providing legal counsel on financial and corporate matters, leveraging his extensive background in capital markets and regulatory affairs.
Previous Experience at Cooley LLP
Before joining Jefferies, Ryan Walker worked as a Capital Markets Attorney at Cooley LLP from 2021 to 2023. During his tenure of two years in New York, he contributed to the firm's legal services focusing on capital markets, helping clients manage complex financial transactions and regulatory compliance.
Role at Weil, Gotshal & Manges LLP
Ryan Walker also served as a Capital Markets Attorney at Weil, Gotshal & Manges LLP from 2019 to 2021. In this role, he spent two years in the Greater New York City Area, where he was involved in high-stakes corporate transactions, including public offerings and private placements.
Educational Background
Ryan Walker holds a Doctor of Law (JD) from Georgetown University Law Center, where he studied from 2016 to 2019. Additionally, he earned a Bachelor of Arts (B.A.) in Political Science and Government from Rutgers University, completing his degree between 2012 and 2016. His academic background has provided him with a strong foundation in both law and political science.
Early Career and Internships
Ryan Walker's early career includes various internships that helped build his expertise in legal and financial sectors. Notably, he interned at the U.S. Commodity Futures Trading Commission (CFTC) and the U.S. Securities and Exchange Commission (SEC) in 2017 and 2018, respectively. These roles allowed him to engage with complex financial instruments and enforcement actions. Additionally, he had a brief stint as a Business Development Intern at The Medicines Company in 2014.